Quality Metrics

For 30 years, PrimeCare Health has provided quality and affordable care to underserved communities in Chicago. Our multilingual providers and staff address unmet need by serving patients of all ages and helping them access our services. In 2022, we were named a Health Center Quality Leader by the Health Resources & Services Administration (HRSA). We were given this recognition for our high rates in clinical quality measures.

The previous year was our first time being recognized as a Health Center Quality Leader. We also received Community Health Center Quality Recognition (CQHR) badges in Target Blood Pressure, Statin Therapy, Target Type 2 Diabetes, Advancing HIT for Quality, and PCMH Recognition.

Although these awards are a great honor for our organization, we thank our dedicated staff and trusted patients who work together every day to foster positive health outcomes for more than 20,000 people across the northwest side of Chicago.

 
We had 30,677 patients in 2023. We are committed to the family medicine approach, which is based on a continuous, comprehensive, and holistic patient-provider relationship.
We had 113,217 visits to our centers in 2022. We seek to improve the health and wellbeing of all individuals & communities that we serve in partnership with aligned health and social service providers.
85% of our patients have public insurance or no insurance. We work with our patients to provide quality, affordable care to a medically underserved population.

Patients aged 12+ with a visit in 2023 who were screened for depression and, if positive, have a follow-up plan documented.

Patients aged 3-17 with a visit in 2023 and a documented BMI percentile, nutrition, and exercise counseling.

78% HIV screening.

Patients aged 15-65 with a visit in 2023 who were screened for HIV.

96% TOBACCO SCREENING AND FOLLOW-UP

Patients aged 13+ with a visit in 2023 who were screened for tobacco use and, if positive, have a follow-up plan documented.

88% statin therapy to treat cardiovascular disease.

Patients aged 21+ at high risk of cardiovascular events who were prescribed a statin during the year.

76% cervical cancer screening.

Patients with a cervix aged 21-29, with a visit in 2023, who had PAP SMEAR within the last three years, or aged 30-64 with PAP SMEAR & HPV co-testing within the past 5 years.

66% breast cancer screening.

Women aged 51-73 with a visit in 2023 who had a mammogram

to screen for

breast cancer.

74% controlling high blood pressure.

Patients with hypertension with a visit in 2023 whose blood pressure was regulated to

<140/90 mmHg.

82% access to prenatal care.

Patients with a visit in 2023 whose first prenatal visit was in their first trimester.